Job title: CEO
Prof. Evren Alici is a distinguished researcher both at the Karolinska Institute, Stockholm, Sweden and at Nova Southeastern University, Fort Lauderdale, FL, USA. His research focus is in the field of multiple myeloma and sarcoma. He has published many research and review articles about multiple myeloma and the use of NK cells against the cancer. He is principal investigator in many ongoing clinical phase I and II trials where autologous NK cells are used to combat the disease. Furthermore, he is an expert in retro- and lentiviral production for clinical use. Prof. Alici has had five doctoral students and has been mentor for 6 postdoctoral fellows, three of which have successfully moved on to senior positions. He has received several fellowships and awards, has accepted several commissions of trust as advisor for companies that focus on cell therapies and he is the inventor of four granted patents.
Strategies to Generate Potent NK Cells as a Universal Source 9:30 am
Outlining strategies to genetically modify NK cells with minimal manipulation in an effective manner A relatively agnostic comparison of strategies to expand autologous and allogeneic NK cell products Highlighting strategies to decrease the lag time of initial cultivation period for NK cell expansion leading to faster time to dose Covering transient gene modification strategies and…Read more
day: Day Two